Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Genlink Pharma Solutions has informed that it has enclosed a Certificate issued under Regulation 40(9) for the company for half year period from 01st April, 2020 to 30th September, 2020.
The above information is a part of company’s filings submitted to BSE.